advertisement
11.15 Other drugs in relation to glaucoma (19)
Showing records 1 to 19
Display all abstracts in classification 11.15 Other drugs in relation to glaucoma
Search within classification 11.15 Other drugs in relation to glaucoma25245 Simvastatin and Disease Stabilization in Normal Tension Glaucoma: A Cohort Study
Leung DY; Li FC; Kwong YY; Tham CC; Chi SC; Lam DS
Ophthalmology 2010; 117: 471-476
25552 Clinical observation of panretinal photocoagulation, vitrectomy combined with pars plana Ahmed glaucoma valve implantation for neovascular glaucoma
Li S -H; Ye J; He X -G
International Journal of Ophthalmology 2009; 9: 1890-1891
25623 Anterior chamber bevacizumab for rubeotic glaucoma secondary to retinal artery occlusion
Bhojwani R; Kelly S P
Artery Research 2009; 3: 122-123
25470 Bevacizumab (Avastin(registered trademark)) for the management of anterior chamber neovascularization and neovascular glaucoma
Brouzas D; Charakidas A; Moschos M; Koutsandrea C; Apostolopoulos M; Baltatzis S
Clinical Ophthalmology 2009; 3: 685-688
25357 Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab
Lupinacci A P C; Calzada J I; Rafieetery M; Charles S; Netland P A
Advances in Therapy 2009; 26: 208-216
25592 Bevacizumab as adjuvant for neovascular glaucoma
Beutel J; Peters S; Luke M; Aisenbrey S; Szurman P; Spitzer M S; Yoeruek E; Grisanti S
Acta Ophthalmologica 2010; 88: 103-109
25422 Intravitreal bevacizumab for neovascular glaucoma
Vasudev D; Blair M P; Galasso J; Kapur R; Vajaranant T
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 453-458
25600 Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma
Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
Acta Ophthalmologica 2010; 88: 96-102
25407 Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim T H; Bae S H; Cho Y J; Lee J H; Kim H K; Sohn Y H
Korean Journal of Ophthalmology 2009; 23: 188-192
25404 Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
Sagong M; Kim J; Chang W
Korean Journal of Ophthalmology 2009; 23: 215-218
25618 Intravitreal Bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: A case report
Alasil T; Rauser M E
Cases Journal 2009; 2: 10: 176
25517 Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy
Liu L; Wu W -C; Yeung L; Wang N -K; Kuo Y -H; Chao A -N; Chen K -J; Chen T -L; Lai C -C; Hwang Y -S
Ophthalmic Surgery Lasers and Imaging 2010; 41: 72-77
25201 Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis)
Sharei V; Höhn F; Köhler T; Hattenbach LO; Mirshahi A
European Journal of Ophthalmology 2010; 20: 174-179
25087 Anti-VEGF therapy for glaucoma
Horsley MB; Kahook MY
Current Opinions in Ophthalmology 2010; 21: 112-117
25397 Advance in the study of complication of anti-vascular endothelial growth factor following intravitreal injection
Meng L; Chen S
Chinese Ophthalmic Research 2009; 27: 1039-1043
25553 Analysis of incidence rate and risk factors of secondary glaucoma after intravitreal injection of triamcinolone acetonide
Liu C -N; Li Y -T
International Journal of Ophthalmology 2009; 9: 1972-1973
25292 Selective trabeculoplasty in combination with vasoactive agents in the complex treatment of primary open-angle glaucoma
Shaimova V A; Shaimov R B; Goloshchapov K P
Vestnik Oftalmologii 2009; 125: 28-31
25459 Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
Kahook M Y; Camejo L; Noecker R J
Clinical Ophthalmology 2009; 3: 29-31
25454 Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma
Chang D T W; Herceg M C; Bilonick R A; Camejo L; Schuman J S; Noecker R J
Clinical Ophthalmology 2009; 3: 345-355